Targeted inhibition of FcRn reduces NET formation to ameliorate experimental ulcerative colitis by accelerating ANCA clearance
出版年份 2022 全文链接
标题
Targeted inhibition of FcRn reduces NET formation to ameliorate experimental ulcerative colitis by accelerating ANCA clearance
作者
关键词
-
出版物
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 113, Issue -, Pages 109474
出版商
Elsevier BV
发表日期
2022-11-21
DOI
10.1016/j.intimp.2022.109474
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expression levels of cellular inhibitor of apoptosis proteins and colitogenic cytokines are inversely correlated with the activation of interferon regulatory factor 4
- (2022) Sho Masaki et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Annickia polycarpa extract attenuates inflammation, neutrophil recruitment, and colon damage during colitis
- (2022) Nathaniel L. Lartey et al. IMMUNOLOGY LETTERS
- Neutrophil Extracellular Traps and Their Implications in Cardiovascular and Inflammatory Disease
- (2021) Johannes Klopf et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Emerging Therapies in Immune Thrombocytopenia
- (2021) Sylvain Audia et al. Journal of Clinical Medicine
- Ulcerative colitis: an update
- (2021) Jonathan P Segal et al. CLINICAL MEDICINE
- IgG regulation through FcRn blocking: A novel mechanism for the treatment of myasthenia gravis
- (2021) Gil I. Wolfe et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- First- and Second-line Pharmacotherapies for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis
- (2020) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies
- (2020) Amandip Kaur et al. Journal of Inflammation-London
- The neonatal Fc receptor in cancer FcRn in cancer
- (2020) Diana Cadena Castaneda et al. Cancer Medicine
- Assessment of clinical activity and severity using serum ANCA and ASCA antibodies in patients with ulcerative colitis
- (2020) Yanhua Pang et al. Allergy Asthma and Clinical Immunology
- The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluation
- (2020) Kip P. Conner et al. PHARMACOLOGY & THERAPEUTICS
- Biologic Therapy for Ulcerative Colitis
- (2020) Abhik Bhattacharya et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Ulcerative Colitis
- (2020) Tanyaporn Kaenkumchorn et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Epidemiology and Pathogenesis of Ulcerative Colitis
- (2020) Lillian Du et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations
- (2020) Hans-Hartmut Peter et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models
- (2020) Roberto de Paula do Nascimento et al. LIFE SCIENCES
- Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative Colitis
- (2019) Vincenzo Dinallo et al. Journal of Crohns & Colitis
- Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review
- (2019) Dong Yeon Jeong et al. AUTOIMMUNITY REVIEWS
- Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor
- (2019) Xiaoyang Liu et al. Nature Communications
- Next-generation Fc receptor–targeting biologics for autoimmune diseases
- (2019) Adrian W. Zuercher et al. AUTOIMMUNITY REVIEWS
- Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
- (2019) Adrian C. Newland et al. AMERICAN JOURNAL OF HEMATOLOGY
- Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex–mediated immune responses
- (2019) L. J. Blumberg et al. Science Advances
- Neutrophil Extracellular Traps: The Biology of Chromatin Externalization
- (2018) Gabriel Sollberger et al. DEVELOPMENTAL CELL
- M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study
- (2018) Leona E. Ling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pathogenesis and therapeutic interventions for ANCA-associated vasculitis
- (2018) Daigo Nakazawa et al. Nature Reviews Rheumatology
- Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview
- (2017) Vidal Delgado-Rizo et al. Frontiers in Immunology
- The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)
- (2016) Maria Weiner et al. AUTOIMMUNITY REVIEWS
- The role of neutrophils and NETosis in autoimmune and renal diseases
- (2016) Sarthak Gupta et al. Nature Reviews Nephrology
- New Insights into Neutrophil Extracellular Traps: Mechanisms of Formation and Role in Inflammation
- (2016) Hang Yang et al. Frontiers in Immunology
- FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin
- (2015) Michal Pyzik et al. JOURNAL OF IMMUNOLOGY
- Immunopathogenesis of IBD: current state of the art
- (2015) Heitor S. P. de Souza et al. Nature Reviews Gastroenterology & Hepatology
- Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel Disease
- (2013) Maria Teresa Arias-Loste et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity
- (2012) M. J. Kaplan et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started